ASCO has published a comprehensive review of progress in clinical cancer research that has come to fruition in 2013. The report highlights advances across the entire continuum of cancer care, from prevention to treatment and survivorship, and covers a broad range of cancer subspecialties. It also documents U.S. Food and Drug Administration approvals of new anticancer agents, clinical practice guidelines, and policy priorities that are likely to influence cancer care delivery in the near-term. Read more here.
Read the full report, Clinical Cancer Advances 2013: ASCO’s Annual Report on Progress Against Cancer, here.
No comments:
Post a Comment